Role of exosomal miRNA-19a/19b and PTEN in brain tumor diagnosis

References

• Tan Y , LuoX, LvWet al. Tumor-derived exosomal components: the multifaceted roles and mechanisms in breast cancer metastasis. Cell Death Dis.12(6), 547 (2021).
   PubMed Web of Science ®Google Scholar
• Mansoori B , BaradaranB, NazariA, GaballuFA, ChoWCS, MansooriB. MicroRNAs in the cancer cell-to-cell communication: an insight into biological vehicles. Biomed. Pharmacother.153, 113449 (2022).
   PubMed Web of Science ®Google Scholar
• Garofalo M , CroceCM. MicroRNAs: master regulators as potential therapeutics in cancer. Annu. Rev. Pharmacol.51, 25–43 (2011).
   Google Scholar
• Silvestro S , MazzonE. MiRNAs as promising translational strategies for neuronal repair and regeneration in spinal cord injury. Cells11(14), 2177 (2022).
   PubMed Web of Science ®Google Scholar
• Peng Y , CroceCM. The role of microRNAs in human cancer. Signal Transduct. Target. Ther.1(1), 1–9 (2016).
   Web of Science ®Google Scholar
• Bhome R , DelVecchio F, LeeGHet al. Exosomal microRNAs (exomiRs): small molecules with a big role in cancer. Cancer Lett.420, 228–235 (2018).
   PubMed Web of Science ®Google Scholar
• Nalamolu KR , VenkateshI, MohandassAet al. Exosomes secreted by the cocultures of normal and oxygen–glucose-deprived stem cells improve post-stroke outcome. Neuromolecular Med.21, 529–539 (2019).
   PubMed Web of Science ®Google Scholar
• Jia Z , WangK, ZhangAet al. miR-19a and miR-19b overexpression in gliomas. Pathol. Oncol. Res.19, 847–853 (2013).
   PubMed Web of Science ®Google Scholar
• Carnero A , Blanco-AparicioC, RennerO, LinkW, LealJF. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr. Cancer Drug Targets8(3), 187–198 (2008).
   PubMed Web of Science ®Google Scholar
• Wang W , LiuL, TianY. miR-19-3p targets PTEN to regulate cervical cancer cell proliferation, invasion, and autophagy. Genet. Res.10.1155/2023/4784500 (2023).
   Web of Science ®Google Scholar
• Sun J , JiaZ, LiBet al. miR-19 regulates the proliferation and invasion of glioma by RUNX3 via β-catenin/Tcf-4 signaling. Oncotarget8(67), 110785 (2017).
   PubMedGoogle Scholar
• Ardizzone A , CalabreseG, CampoloMet al. Role of miRNA-19a in cancer diagnosis and poor prognosis. Int. J. Mol. Sci.22(9), 4697 (2021).
   PubMed Web of Science ®Google Scholar
• Wang W , ZhangA, HaoY, WangG, JiaZ. The emerging role of miR-19 in glioma. J. Cell. Mol. Med.22(10), 4611–4616 (2018).
   PubMed Web of Science ®Google Scholar
• Blanco-Aparicio C , RennerO, LealJF, CarneroA. PTEN, more than the AKT pathway. Carcinogenesis28(7), 1379–1386 (2007).
   PubMed Web of Science ®Google Scholar
• Liu C , WuH, LiYet al. SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway. J. Neurooncol.135, 263–272 (2017).
   PubMed Web of Science ®Google Scholar
• Ruan J , ChenH, KurganL, ChenK, KangC, PuP. HuMiTar: a sequence-based method for prediction of human microRNA targets. Algorithms Mol. Biol.3, 1–12 (2008).
   PubMed Web of Science ®Google Scholar
• Jia Z , WangK, ZhangAet al. miR-19a and miR-19b overexpression in gliomas. Pathol. Oncol. Res.19, 847–853 (2013).
   PubMed Web of Science ®Google Scholar
• Dobson RC , PatelTR. Analytical ultracentrifugation: still the gold standard that offers multiple solutions. Eur. Biophys. J.49, 673–676 (2020).
   PubMed Web of Science ®Google Scholar
• Wu Y , DengW, KlinkeDJII. Exosomes: improved methods to characterize their morphology, RNA content, and surface protein biomarkers. Analyst140(19), 6631–6642 (2015).
   PubMed Web of Science ®Google Scholar
• Shao H , ChungJ, BalajLet al. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat. Med.18(12), 1835–1840 (2012).
   PubMed Web of Science ®Google Scholar
• Mian SY , NambiarA, KaliaperumalC. Phytotherapy for the treatment of glioblastoma: a review. Front. Surg.9, 844993 (2022).
   PubMed Web of Science ®Google Scholar
• Ostrom QT , GittlemanH, TruittG, BosciaA, KruchkoC, Barnholtz-SloanJS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro-Oncology20(Suppl. 4), iv1–iv86 (2018).
   PubMedGoogle Scholar
• Wrensch M , LeeM, MiikeR, NewmanB, BargarG, DavisR. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am. J. Epidemiol.145(7), 581–593 (1997).
   PubMed Web of Science ®Google Scholar
• Ostrom QT , AdelFahmideh M, CoteDJet al. Risk factors for childhood and adult primary brain tumors. Neuro-Oncology21(11), 1357–1375 (2019).
   PubMed Web of Science ®Google Scholar
• Peter ID , LinetMS, HeinemanEF. Etiology of brain tumors in adults. Epidemiol. Rev.17(2), 382–414 (1995).
   PubMed Web of Science ®Google Scholar
• Kim SJH , IoannidesSJ, ElwoodJM. Trends in incidence of primary brain cancer in New Zealand, 1995 to 2010. Aust. N. Z. J. Public Health39(2), 148–152 (2015).
   PubMed Web of Science ®Google Scholar
• Malmir H , ShayanfarM, Mohammad-ShiraziM, TabibiH, SharifiG, EsmaillzadehA. Tea and coffee consumption in relation to glioma: a case–control study. Eur. J. Nutr.58, 103–111 (2019).
   PubMed Web of Science ®Google Scholar
• Ogawa T , SawadaN, IwasakiMet al. Coffee and green tea consumption in relation to brain tumor risk in a Japanese population. Int. J. Cancer139(12), 2714–2721 (2016).
   PubMed Web of Science ®Google Scholar
• Harding CV , HeuserJE, StahlPD. Exosomes: looking back three decades and into the future. J Cell Biol200(4), 367 (2013).
   PubMed Web of Science ®Google Scholar
• Karami Fath M , AzamiJ, MasoudiA, MosaddeghiHeris R, RahmaniE, AlaviF. Exosome-based strategies for diagnosis and therapy of glioma cancer. Cancer Cell. Int.22(1), 262 (2022).
   PubMed Web of Science ®Google Scholar
• Wang J , ZhengY, ZhaoM. Exosome-based cancer therapy: implication for targeting cancer stem cells. Front. Pharmacol.7, 533 (2017).
   PubMed Web of Science ®Google Scholar
• Olive V , BennettMJ, WalkerJCet al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev.23(24), 2839–2849 (2009).
   PubMed Web of Science ®Google Scholar
• Zhi F , ShaoN, WangRet al. Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma. Neuro-Oncology17(3), 383–391 (2015).
   PubMed Web of Science ®Google Scholar
• Liu HN , WuH, TsengYJet al. Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer. BMC Cancer18(1), 1–11 (2018).
   PubMedGoogle Scholar
• Sierzega M , KaczorM, KolodziejczykP, KuligJ, SanakM, RichterP. Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331. Br. J. Cancer117(2), 266–273 (2017).
   PubMed Web of Science ®Google Scholar
• Wang F , LiT, ZhangBet al. MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN. Biochem. Biophys. Res. Commun.434(3), 688–694 (2013).
   PubMed Web of Science ®Google Scholar
• Wu TY , ZhangTH, QuLMet al. miR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression. Int. J. Clin. Exp. Pathol.7(1), 56 (2014).
   PubMed Web of Science ®Google Scholar
• Tantawy M , ElzayatMG, YehiaD, TahaH. Identification of microRNA signature in different pediatric brain tumors. Genet. Mol. Biol.41, 27–34 (2018).
   PubMed Web of Science ®Google Scholar
• Petrocca F , VisoneR, OnelliMRet al. E2F1-regulated microRNAs impair TGFβ-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell13(3), 272–286 (2008).
   PubMed Web of Science ®Google Scholar
• Weng LP , BrownJL, EngC. PTEN coordinates G1 arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Hum. Mol. Genet.10(6), 599–604 (2001).
   PubMed Web of Science ®Google Scholar
• Qin N , TongGF, SunLW, XuXL. Long noncoding RNA MEG3 suppresses glioma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of miR-19a. Oncol. Res. Pre-Clin. Clin. Cancer Ther.25(9), 1471–1478 (2017).
   Google Scholar
• Patnam S , SamalR, KoyyadaRet al. Exosomal PTEN as a predictive marker of aggressive gliomas. Neurol. India70(1), 215 (2022).
   PubMed Web of Science ®Google Scholar
• Jiang TY , ShiYY, CuiXWet al. PTEN deficiency facilitates exosome secretion and metastasis in cholangiocarcinoma by impairing TFEB-mediated lysosome biogenesis. Gastroenterology164(3), 424–438 (2023).
   PubMed Web of Science ®Google Scholar
• Gabriel K , IngramA, AustinRFet al. Regulation of the tumor suppressor PTEN through exosomes: a diagnostic potential for prostate cancer. PLOS ONE8(7), e70047 (2013).
   PubMed Web of Science ®Google Scholar
• Koul D . PTEN signaling pathways in glioblastoma. Cancer Biol.Ther.7(9), 1321–1325 (2008).
   PubMed Web of Science ®Google Scholar
• Silvestro S , MazzonE. MiRNAs as promising translational strategies for neuronal repair and regeneration in spinal cord injury. Cells11(14), 2177 (2022).
   PubMed Web of Science ®Google Scholar
• Ding C , QianC, HouSet al. Exosomal miRNA-320a is released from hAMSCs and regulates SIRT4 to prevent reactive oxygen species generation in POI. Mol. Ther. Nucleic Acids21, 37–50 (2020).
   PubMedGoogle Scholar